Move will incentivize firms to boost domestic production of APIs and reduce dependence on China. Currently, India imports almost all its bulk drugs, especially from Chinafrom Moneycontrol Business News https://ift.tt/2mNpaae
Move will incentivize firms to boost domestic production of APIs and reduce dependence on China. Currently, India imports almost all its bulk drugs, especially from China
Comments
Post a Comment